Recruitment of patients for the trials has begun. This Phase I trial is designed as a dose-escalation study to evaluate the safety profile of HG-CT-1 in adult patients with R/R AML. Key secondary ...

INR:1937. rummy signup bonus Phase 3 clinical trial of S1P receptor modulator jointly developed by Everest Pharmaceuticals begins with patient recruitment R&D ...

Dimerix (ASX:DXB) secured orphan drug designation for the treatment in the US and Europe, opening the door to a faster ...

INR:6263. 23 tarikh ka lottery TaiGen Biopharma's new anti-influenza drug is approved for clinical trials in the U.S., without the restriction of taking the ...

INR:7155. singam lottery apps K drug/chemotherapy combination failed in phase III clinical trial of bladder cancer Transcenta's TST001 completed first patient ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing ...

Alon Kahana, MD, PhD, discusses the role of interleukin-6 in thyroid eye disease and the potential of tourmaline Bio's IL-6 ...